US Stock MarketDetailed Quotes

HCW Biologics (HCWB)

Watchlist
  • 1.250
  • -0.070-5.30%
Trading Jun 12 14:35 ET
8.95MMarket Cap-0.15P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

HCW Biologics (HCWB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
55.17%-1.58M
5.87%-13.39M
-18.37%-3.36M
-10.71%-3.24M
32.49%-3.28M
2.50%-3.51M
36.81%-14.23M
27.21%-2.83M
47.64%-2.93M
48.23%-4.86M
Net income from continuing operations
258.06%3.47M
73.49%-7.96M
121.32%719.23K
-16.71%-4.55M
87.38%-1.93M
70.58%-2.2M
-20.12%-30.02M
68.42%-3.37M
20.98%-3.9M
-254.99%-15.28M
Operating gains losses
----
---5.2M
---5.38M
----
----
----
----
----
----
----
Depreciation and amortization
-66.10%142.05K
-12.04%1.04M
-77.01%156.94K
35.39%173.91K
124.67%291.92K
72.08%419.01K
4.33%1.18M
148.59%682.51K
-53.70%128.45K
-54.30%129.93K
Other non cash items
-2,878.23%-4.17M
-247,976.79%-1.04M
---1.06M
---1
---131.13K
35,985.17%150K
74.99%-418
--0
--0
--0
Change In working capital
52.24%-1.03M
-120.45%-2.78M
17.09%-361.65K
-134.71%-213.43K
-100.45%-44.97K
-164.02%-2.16M
392.99%13.6M
-143.59%-436.19K
155.57%614.93K
281.91%10.05M
-Change in receivables
-108.63%-42.67K
-42.32%550.03K
-102.17%-1.51K
-389.05%-9.06K
-73.53%65.88K
-21.71%494.71K
185.29%953.56K
108.43%69.64K
209.28%3.13K
154.77%248.91K
-Change in prepaid assets
54.29%-117.88K
-82.93%141.99K
-910.93%-20.91K
25.96%157.75K
-34.43%263.05K
-185.21%-257.89K
117.26%831.62K
-99.62%2.58K
162.25%125.24K
107.32%401.17K
-Change in payables and accrued expense
44.05%-1.34M
-129.25%-3.47M
33.28%-339.23K
-174.42%-362.12K
-103.98%-373.91K
-196.00%-2.4M
633.30%11.87M
-141.45%-508.4K
159.33%486.56K
1,801.51%9.4M
-Change in other current liabilities
----
--0
--0
--0
--0
--0
82.70%-56.54K
--0
--0
--0
-Change in other working capital
--470K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
55.17%-1.58M
5.87%-13.39M
-18.37%-3.36M
-10.71%-3.24M
32.49%-3.28M
2.50%-3.51M
36.81%-14.23M
27.21%-2.83M
47.64%-2.93M
48.23%-4.86M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
0
-106.89%-261.62K
96.95%-113.41K
-100.40%-37.06K
101.19%18.57K
Net PPE purchase and sale
--0
--0
--0
--0
--0
--0
95.78%-261.62K
96.95%-113.41K
94.12%-37.06K
101.19%18.57K
Net investment purchase and sale
----
----
----
----
----
----
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
-106.89%-261.62K
96.95%-113.41K
-100.40%-37.06K
101.19%18.57K
Financing cash flow
Cash flow from continuing financing activities
1,703.75%851.64K
-31.47%10.67M
-36.43%4.21M
-32.23%1.9M
140.18%4.61M
-101.26%-53.1K
107,217.90%15.57M
43,540.29%6.62M
31,576.24%2.8M
24,807.64%1.92M
Net issuance payments of debt
-698.84%-259.3K
-99.67%22.38K
-109.55%-32.85K
-101.12%-31.39K
-93.80%119.08K
-101.89%-32.46K
17,829.48%6.79M
1,274.35%343.99K
31,281.84%2.8M
--1.92M
Net common stock issuance
--0
24.31%8.03M
15.27%4.57M
--1.99M
--1.47M
-99.93%1.65K
27,124.54%6.46M
28,105.20%3.96M
--0
--0
Proceeds from stock option exercised by employees
--1.11M
29.23%3.82M
--0
----
----
--0
--2.96M
--2.96M
----
----
Net other financing activities
----
-89.61%-1.21M
---321.38K
---63.5K
---802.6K
---22.3K
---638.05K
----
----
----
Cash from discontinued financing activities
Financing cash flow
1,703.75%851.64K
-31.47%10.67M
-36.43%4.21M
-32.23%1.9M
140.18%4.61M
-101.26%-53.1K
107,217.90%15.57M
43,540.29%6.62M
31,576.24%2.8M
24,807.64%1.92M
Net cash flow
Beginning cash position
-58.23%1.95M
30.03%4.67M
9.89%1.1M
110.02%2.44M
-72.88%1.11M
30.03%4.67M
-83.90%3.6M
-91.10%998.22K
-84.41%1.16M
-77.79%4.08M
Current changes in cash
79.71%-723.59K
-352.17%-2.72M
-76.73%855.56K
-722.88%-1.34M
145.55%1.33M
-829.48%-3.57M
105.76%1.08M
148.21%3.68M
-104.32%-163.09K
73.29%-2.92M
End cash Position
10.95%1.23M
-58.23%1.95M
-58.23%1.95M
9.89%1.1M
110.02%2.44M
-72.88%1.11M
30.03%4.67M
30.03%4.67M
-91.10%998.22K
-84.41%1.16M
Free cash flow
55.17%-1.58M
7.57%-13.39M
-13.81%-3.36M
-9.33%-3.24M
32.23%-3.28M
5.89%-3.51M
49.54%-14.49M
61.26%-2.95M
52.35%-2.96M
55.76%-4.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 55.17%-1.58M5.87%-13.39M-18.37%-3.36M-10.71%-3.24M32.49%-3.28M2.50%-3.51M36.81%-14.23M27.21%-2.83M47.64%-2.93M48.23%-4.86M
Net income from continuing operations 258.06%3.47M73.49%-7.96M121.32%719.23K-16.71%-4.55M87.38%-1.93M70.58%-2.2M-20.12%-30.02M68.42%-3.37M20.98%-3.9M-254.99%-15.28M
Operating gains losses -------5.2M---5.38M----------------------------
Depreciation and amortization -66.10%142.05K-12.04%1.04M-77.01%156.94K35.39%173.91K124.67%291.92K72.08%419.01K4.33%1.18M148.59%682.51K-53.70%128.45K-54.30%129.93K
Other non cash items -2,878.23%-4.17M-247,976.79%-1.04M---1.06M---1---131.13K35,985.17%150K74.99%-418--0--0--0
Change In working capital 52.24%-1.03M-120.45%-2.78M17.09%-361.65K-134.71%-213.43K-100.45%-44.97K-164.02%-2.16M392.99%13.6M-143.59%-436.19K155.57%614.93K281.91%10.05M
-Change in receivables -108.63%-42.67K-42.32%550.03K-102.17%-1.51K-389.05%-9.06K-73.53%65.88K-21.71%494.71K185.29%953.56K108.43%69.64K209.28%3.13K154.77%248.91K
-Change in prepaid assets 54.29%-117.88K-82.93%141.99K-910.93%-20.91K25.96%157.75K-34.43%263.05K-185.21%-257.89K117.26%831.62K-99.62%2.58K162.25%125.24K107.32%401.17K
-Change in payables and accrued expense 44.05%-1.34M-129.25%-3.47M33.28%-339.23K-174.42%-362.12K-103.98%-373.91K-196.00%-2.4M633.30%11.87M-141.45%-508.4K159.33%486.56K1,801.51%9.4M
-Change in other current liabilities ------0--0--0--0--082.70%-56.54K--0--0--0
-Change in other working capital --470K------------------------------------
Cash from discontinued investing activities
Operating cash flow 55.17%-1.58M5.87%-13.39M-18.37%-3.36M-10.71%-3.24M32.49%-3.28M2.50%-3.51M36.81%-14.23M27.21%-2.83M47.64%-2.93M48.23%-4.86M
Investing cash flow
Cash flow from continuing investing activities 000000-106.89%-261.62K96.95%-113.41K-100.40%-37.06K101.19%18.57K
Net PPE purchase and sale --0--0--0--0--0--095.78%-261.62K96.95%-113.41K94.12%-37.06K101.19%18.57K
Net investment purchase and sale --------------------------0--0--------
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0-106.89%-261.62K96.95%-113.41K-100.40%-37.06K101.19%18.57K
Financing cash flow
Cash flow from continuing financing activities 1,703.75%851.64K-31.47%10.67M-36.43%4.21M-32.23%1.9M140.18%4.61M-101.26%-53.1K107,217.90%15.57M43,540.29%6.62M31,576.24%2.8M24,807.64%1.92M
Net issuance payments of debt -698.84%-259.3K-99.67%22.38K-109.55%-32.85K-101.12%-31.39K-93.80%119.08K-101.89%-32.46K17,829.48%6.79M1,274.35%343.99K31,281.84%2.8M--1.92M
Net common stock issuance --024.31%8.03M15.27%4.57M--1.99M--1.47M-99.93%1.65K27,124.54%6.46M28,105.20%3.96M--0--0
Proceeds from stock option exercised by employees --1.11M29.23%3.82M--0----------0--2.96M--2.96M--------
Net other financing activities -----89.61%-1.21M---321.38K---63.5K---802.6K---22.3K---638.05K------------
Cash from discontinued financing activities
Financing cash flow 1,703.75%851.64K-31.47%10.67M-36.43%4.21M-32.23%1.9M140.18%4.61M-101.26%-53.1K107,217.90%15.57M43,540.29%6.62M31,576.24%2.8M24,807.64%1.92M
Net cash flow
Beginning cash position -58.23%1.95M30.03%4.67M9.89%1.1M110.02%2.44M-72.88%1.11M30.03%4.67M-83.90%3.6M-91.10%998.22K-84.41%1.16M-77.79%4.08M
Current changes in cash 79.71%-723.59K-352.17%-2.72M-76.73%855.56K-722.88%-1.34M145.55%1.33M-829.48%-3.57M105.76%1.08M148.21%3.68M-104.32%-163.09K73.29%-2.92M
End cash Position 10.95%1.23M-58.23%1.95M-58.23%1.95M9.89%1.1M110.02%2.44M-72.88%1.11M30.03%4.67M30.03%4.67M-91.10%998.22K-84.41%1.16M
Free cash flow 55.17%-1.58M7.57%-13.39M-13.81%-3.36M-9.33%-3.24M32.23%-3.28M5.89%-3.51M49.54%-14.49M61.26%-2.95M52.35%-2.96M55.76%-4.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.78%
Sample Name
Sample Code
 +0.49%
Sample Name
Sample Code
 -1.92%
4
ProShares Ultra Energy
DIG
-2.15%
5
VanEck Oil Services ETF
OIH
-2.65%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.53%
Sample Name
Sample Code
 +10.15%
Sample Name
Sample Code
 +10.12%
4
Qifu Technology
QFIN
+6.19%
5
NetEase
NTES
+5.71%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran negotiations have entered a critical window! According to Bloomberg, both sides are close to signing a memorandum of understan Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -